Skip to content

Drug interactions

Netupitant-palonosetron + Selegiline transdermal

Severity: Moderate

Netupitant-palonosetron and Selegiline transdermal: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Palonosetron has been rarely linked to serotonin syndrome with serotonergic drugs. Transdermal selegiline is an MAO inhibitor at antidepressant doses, which may increase the potential for serotonergic toxicity.

What this interaction means in plain words

Netupitant-palonosetron and Selegiline transdermal can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Evidence level: Low

Why it happens

Possible additive serotonergic effects with MAO inhibition; the role of 5-HT3 antagonism is not well established.

What to do

Monitor for serotonin syndrome signs after administering the antiemetic. Stop serotonergic drugs and give supportive care if symptoms develop.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Netupitant-palonosetron and Selegiline transdermal, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Netupitant-palonosetron with Selegiline transdermal?

MediHelp rates the interaction as moderate. Netupitant-palonosetron and Selegiline transdermal can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Palonosetron has been rarely linked to serotonin syndrome with serotonergic drugs. Transdermal selegiline is an MAO inhibitor at antidepressant doses, which may increase the potential for serotonergic toxicity.

How serious is the interaction between Netupitant-palonosetron and Selegiline transdermal?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for serotonin syndrome signs after administering the antiemetic. Stop serotonergic drugs and give supportive care if symptoms develop.

What other medicines interact with Netupitant-palonosetron?

MediHelp also lists interactions of Netupitant-palonosetron with, for example, Apomorphine, Flibanserin, Apalutamide. The full list is on the Netupitant-palonosetron page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in